GenEdit

GenEdit

Verified
Developing innovative therapies through targeted delivery of genetic medicines.

Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$96—144m (Dealroom.co estimates Jan 2024.)
South San Francisco California (HQ)
  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor

$0.0

round
investor investor

$0.0

round
investor investor investor investor

$0.0

round
investor investor investor investor investor investor investor investor investor investor investor investor

$0.0

round
*

$24.0m

Series A
Total Funding000k

Recent News about GenEdit

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.